Middle East & Africa Vascular Closure Device Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis - by Product Type (Active Approximators, Passive Approximators, and External Hemostatic Devices), Access (Femoral Access and Radial Access), Procedure (Interventional Cardiology, Interventional Radiology, and Endovascular Surgery), and End User (Hospitals, Ambulatory Surgical Centers, and Others)


No. of Pages: 89    |    Report Code: BMIRE00029952    |    Category: Life Sciences

Middle East & Africa Vascular Closure Device Market
Buy Now
The Middle East & Africa vascular closure device market was valued at US$ 78.28 million in 2022 and is expected to reach US$ 129.04 million by 2030; it is estimated to record a CAGR of 6.4% from 2022 to 2030.

Burgeoning Demand for Minimally Invasive Devices Drives Middle East & Africa Vascular Closure Device Market

Improvements in medical science and technologies have given way to minimally invasive devices, which can aid in the replacement of traditional painful surgical methods by minimally invasive or noninvasive methods. Minimally invasive techniques have gained popularity in surgical fields such as cardiac surgery. Many of these procedures are performed using femoral cannulation for extracorporeal circulation. Vascular closure devices have gained popularity as they reduce the invasiveness and supersede surgical cut-down to cannulate the femoral artery. Vascular closure devices are mainly used in transcatheter and endovascular interventions to enable wound healing and reduce procedure time. Angiography is one of the common procedures performed in a wide variety of specialties, including vascular surgery, interventional radiology, and diagnostic and interventional cardiology. Vascular closure devices are useful in the settings of a large body habitus, anticoagulation, and antiplatelet therapies. They are also used in cases where extended bed rest may not be desirable (such as a patient with extensive pressure ulcers). A vascular closure device with resorbable collagen material, which eliminates the use of suture materials, has been introduced for transfemoral transcatheter aortic valve implantation (TAVI). For instance, the MANTA device by Teleflex Medical Inc. is adequate for the closure of arterial access sites of up to 25 Fr. Safety and efficacy of the system were demonstrated in a real-world TAVI patient cohort. Thus, the increasing demand for minimally invasive devices drives the vascular closure devices market growth.

Middle East & Africa Vascular Closure Device Market Overview

Israel, Iran, Iraq, Kuwait, Oman, Egypt, and Kenya are among the major countries in the Rest of the Middle East & Africa. Growing healthcare spending for better healthcare services is a significant factor contributing to the vascular closure devices market growth in the Rest of the Middle East & Africa. According to the World Bank Group, the healthcare expenditure of Kuwait and Israel is 6.31% and 8.32% of their GDP, respectively. These countries have been focusing on developing their medical device industry. Further, the high prevalence of cardiovascular diseases such as coronary artery disease and cardiac disorders in countries such as Israel, Egypt, and Lebanon propel the demand for surgical procedures. Thus, the high prevalence of cardiovascular disease and significant healthcare expenditure are the notable factors fueling the demand for minimally invasive surgical devices in the Rest of the Middle East & Africa, eventually propelling the vascular closure devices market growth.

Middle East & Africa Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Vascular Closure Device Market Segmentation

The Middle East & Africa vascular closure device market is segmented based on product type, access, procedure, end user, and country.

Based on product type, the Middle East & Africa vascular closure device market is segmented into active approximators, passive approximators, and external hemostatic devices. The passive approximators segment held the largest share in 2022. The active approximators segment is further segmented into suture mediated device and staple clips mediated device. The passive approximators segment is further segmented into sealant and gel based, compression devices, and collagen plug.

By access, the Middle East & Africa vascular closure device market is bifurcated into femoral access and radial access. The femoral access segment held a larger share in 2022.

By procedure, the Middle East & Africa vascular closure device market is segmented into interventional cardiology, interventional radiology, and endovascular surgery. The interventional cardiology access segment held the largest share in 2022.

In terms of end use, the Middle East & Africa vascular closure device market is categorized into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share in 2022.

Based on country, the Middle East & Africa vascular closure device market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. The Rest of Middle East & Africa dominated the Middle East & Africa vascular closure device market in 2022.

Abbott Laboratories, Becton Dickinson and Co, Cardinal Health Inc, Cordis Corp, Haemonetics Corp, Medtronic Plc, and Teleflex Inc are some of the leading companies operating in the Middle East & Africa vascular closure device market.

Middle East & Africa Vascular Closure Device Strategic Insights

Strategic insights for the Middle East & Africa Vascular Closure Device provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/middle-east-and-africa-vascular-closure-device-market-strategic-framework.webp
Get more information on this report

Middle East & Africa Vascular Closure Device Report Scope

Report Attribute Details
Market size in 2022 US$ 78.28 Million
Market Size by 2030 US$ 129.04 Million
Global CAGR (2022 - 2030) 6.4%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Product Type
  • Active Approximators
  • Passive Approximators
  • External Hemostatic Devices
By Access
  • Femoral Access
  • Radial Access
By Procedure
  • Interventional Cardiology
  • Interventional Radiology
  • Endovascular Surgery
By End User
  • Hospitals
  • Ambulatory Surgical Centers
Regions and Countries Covered Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott Laboratories
  • Becton Dickinson and Co
  • Cardinal Health Inc
  • Cordis Corp
  • Haemonetics Corp
  • Medtronic Plc
  • Teleflex Inc
  • Get more information on this report

    Middle East & Africa Vascular Closure Device Regional Insights

    The geographic scope of the Middle East & Africa Vascular Closure Device refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/middle-east-and-africa-vascular-closure-device-market-geography.webp
    Get more information on this report

    The List of Companies - Middle East & Africa Vascular Closure Device Market

    1. Abbott Laboratories

    2. Becton Dickinson and Co

    3. Cardinal Health Inc

    4. Cordis Corp

    5. Haemonetics Corp

    6. Medtronic Plc

    7. Teleflex Inc

    Frequently Asked Questions
    How big is the Middle East & Africa Vascular Closure Device Market?

    The Middle East & Africa Vascular Closure Device Market is valued at US$ 78.28 Million in 2022, it is projected to reach US$ 129.04 Million by 2030.

    What is the CAGR for Middle East & Africa Vascular Closure Device Market by (2022 - 2030)?

    As per our report Middle East & Africa Vascular Closure Device Market, the market size is valued at US$ 78.28 Million in 2022, projecting it to reach US$ 129.04 Million by 2030. This translates to a CAGR of approximately 6.4% during the forecast period.

    What segments are covered in this report?

    The Middle East & Africa Vascular Closure Device Market report typically cover these key segments-

    • Product Type (Active Approximators, Passive Approximators, External Hemostatic Devices)
    • Access (Femoral Access, Radial Access)
    • Procedure (Interventional Cardiology, Interventional Radiology, Endovascular Surgery)
    • End User (Hospitals, Ambulatory Surgical Centers)

    What is the historic period, base year, and forecast period taken for Middle East & Africa Vascular Closure Device Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Vascular Closure Device Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Middle East & Africa Vascular Closure Device Market?

    The Middle East & Africa Vascular Closure Device Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott Laboratories
  • Becton Dickinson and Co
  • Cardinal Health Inc
  • Cordis Corp
  • Haemonetics Corp
  • Medtronic Plc
  • Teleflex Inc
  • Who should buy this report?

    The Middle East & Africa Vascular Closure Device Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East & Africa Vascular Closure Device Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now